Eu Yan Sang returns to the black in Q2, with net profit of $4.7 million
TRADITIONAL Chinese medicine retailer Eu Yan Sang returned to the black, with a second quarter net profit of $4.7 million.
The company reported a loss of $2.8 million in the same period in 2011. This stemmed from an $8.8 million impairment made in writing off the equity investment in Healthzone.
Revenue for the three months to Dec 31 rose by 12 per cent to $77.9 million.
Operating profit fell by 15 per cent to $6.6 million, mainly due to higher operating expenses in Australia and higher rentals in the core markets.